CCNB2 and neoplasm: These good prognosis tumours were mainly characterised by over-expression of ERBB3 and down-regulation of cell cycle-related genes such as CCNA2 and CCNB2. Notably, ERBB3 expression has recently been associated with favorable clinical outcome of invasive ductal carcinomas (Lee et al, 2007).